Compare Lustrum:K Pharma,Inc.:4896

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index K Pharma,Inc. 4896 Medicals 東証グロース December 1, 2000 2023.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

K Pharma,Inc. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Balance Sheet 2023年12月期 K Pharma,Inc. Balance Sheet 2022年12月期 K Pharma,Inc. Balance Sheet 2021年12月期 K Pharma,Inc. Balance Sheet 2020年12月期 K Pharma,Inc. Balance Sheet 年0月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Cash and Cash Equivalents
(Percent)
3,266up
(98.6%)up
1,337up
(97.3%)up
189
(91.7%)
189
(91.7%)

-
Other Current AssetsHelp
(Percent)
43up
(1.3%)down
34up
(2.5%)down
16
(7.7%)
16
(7.7%)

-
Tangible Fixed AssetsHelp
(Percent)

-

-

-

-

-
Intangible Fixed AssetHelp
(Percent)
0
-
0
-
0
-
0
-

-
Investments and OthersHelp
(Percent)
5up
(0.1%)down
4up
(0.3%)down
1
(0.5%)
1
(0.5%)

-
Total AssetsHelp
(Percent)
3,314
(100%)
1,375
(100%)
206
(100%)
206
(100%)
-
(100%)
Total Current LiabilitiesHelp
(Percent)
209up
(6.3%)up
38up
(2.8%)down
27
(13.1%)
27
(13.1%)

-
Total Long-term LiabilitiesHelp
(Percent)
0
-
0
-
0
-
0
-

-
Shareholder's EquityHelp
(Percent)
3,105up
(93.7%)down
1,336up
(97.2%)up
179
(86.9%)
179
(86.9%)

-
Total LiabilitiesHelp
(Percent)
3,314
(100%)
1,375
(100%)
206
(100%)
206
(100%)
-
(100%)

K Pharma,Inc. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Profit and Loss Account 2023年12月期 K Pharma,Inc. Profit and Loss Account 2022年12月期 K Pharma,Inc. Profit and Loss Account 2021年12月期 K Pharma,Inc. Profit and Loss Account 2020年12月期 K Pharma,Inc. Profit and Loss Account 年0月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Amount of Sales
(Percent)
1,000
(100%)
0
(100%)
0
(100%)
0
(100%)
-
(100%)
Total Sales
(Percent)
1,000
(100%)
0
(100%)
0
(100%)
0
(100%)
-
(100%)
Cost of SalesHelp
(Percent)

-

-
90

-

-
Other Costs and RevenueHelp 740up
(74.0%)
392up
139down
229

-
Total CostsHelp 740 392 229 229 -
Net RevenueHelp
-

-
-90

-

-
Earnings Before TaxHelp 301up
(30.1%)
-391down
-229
-229

-
Net IncomeHelp 260up
(26.0%)
-392down
-229
-229

-
当期純利益 260 -392 -229 -229 -

K Pharma,Inc. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

K Pharma,Inc. Cash Flow Statement 2023年12月期 K Pharma,Inc. Cash Flow Statement 2022年12月期 K Pharma,Inc. Cash Flow Statement 2021年12月期 K Pharma,Inc. Cash Flow Statement 2020年12月期 K Pharma,Inc. Cash Flow Statement 年0月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date December 31, 2023 December 31, 2022 December 31, 2021 December 31, 2020
Operating Cash Flow(OFC)Help
(Percent)
454up
(23.4%)up
-363down
(-23.5%)up
-196
(-53.3%)
-196
(-53.3%)

-
Investing Cash Flow(ICF)Help
(Percent)
-11up
(-0.6%)up
-33down
(-2.1%)down
-0
(-0.1%)
-0
(-0.1%)

-
Financing Cash FlowHelp
(Percent)
1,486down
(76.6%)down
1,544up
(100.0%)
368
(100.0%)
368
(100.0%)

-
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
0
-
0
-
0
-
0
-

-
Net Increase and Decrease in Cash and Cash Equivalentsn 1,930up
(99.4%)up
1,148up
(74.3%)up
172
(46.6%)
172
(46.6%)

-

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

K Pharma,Inc.

Company where related level is highHelp

FunPep Company Limited
STELLA PHARMA CORPORATION
OncoTherapy Science,Inc.
Fuso Pharmaceutical Industries, Ltd.
SymBio Pharmaceuticals Limited
Modalis Therapeutics Corporation
MIZUHO MEDY CO.,LTD.
Kringle Pharma,Inc.
Carna Biosciences,Inc.
RIBOMIC Inc.